The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 31, 2023

Filed:

Jul. 27, 2020
Applicant:

Fresenius Medical Care Holdings, Inc., Waltham, MA (US);

Inventors:

Peter Kotanko, New York, NY (US);

Stephan Thijssen, New York, NY (US);

Israel Campos, Morelia, MX;

Hanje Zhang, Rutherford, NJ (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 1/16 (2006.01); A61M 1/14 (2006.01); A61M 1/34 (2006.01); A61M 1/36 (2006.01); A61B 5/02 (2006.01); A61B 5/029 (2006.01); A61B 5/08 (2006.01); A61B 5/145 (2006.01); A61B 5/1455 (2006.01); A61B 5/00 (2006.01);
U.S. Cl.
CPC ...
A61M 1/1601 (2014.02); A61B 5/02 (2013.01); A61B 5/029 (2013.01); A61B 5/02028 (2013.01); A61B 5/0816 (2013.01); A61B 5/14535 (2013.01); A61B 5/14542 (2013.01); A61B 5/14551 (2013.01); A61B 5/14557 (2013.01); A61B 5/4836 (2013.01); A61B 5/7275 (2013.01); A61M 1/14 (2013.01); A61M 1/1613 (2014.02); A61M 1/34 (2013.01); A61M 1/3624 (2013.01); A61M 2205/52 (2013.01); A61M 2230/205 (2013.01);
Abstract

Techniques and apparatuses for determining an estimated cardiac output for a patient during dialysis treatment are described. In one embodiment, for example, an apparatus may include a memory and logic coupled to the memory. The logic may be configured to determine an upper body oxygen consumption for a patient, determine, during a dialysis process: a hemoglobin concentration and a venous oxygen saturation measured via an optical blood monitor operably coupled to an extracorporeal circuit of a dialysis system performing the dialysis process; an arterial oxygen saturation measured via a pulse oximeter operably coupled to the extracorporeal circuit; an arterial-venous oxygen content difference based on the arterial oxygen saturation and the venous oxygen saturation; and an upper body blood flow (UBBF) as (upper body oxygen consumption)/(arterial-venous oxygen content difference), and determine a treatment recommendation based on the upper body blood flow. Other embodiments are described.


Find Patent Forward Citations

Loading…